Immunity-boosting treatment enhances CAR-T cell therapy for blood cancers
A study from the Washington University School of Medicine shows that treatment with the immunity boosting protein interleukin 7 (IL-7) after an infusion of genetically modified T cells causes the cancer-fighting CAR-T cells to grow in number and become more effective at killing tumor cells.
Rapid Ebola diagnosis may be possible with new technology
A new study from researchers at Washington University School of Medicine and colleagues at other institutions details a new tool that can quickly identify the presence of Ebola virus in blood samples. The technology has potential to be developed into a rapid diagnostic test.
Lishko named BJC Investigator
Polina V. Lishko, a noted molecular biologist and entrepreneur, has been named a BJC Investigator at Washington University School of Medicine.
Researchers to study leader cells in breast cancer model
Gregory D. Longmore, MD, at the School of Medicine, and Amit Pathak, at the McKelvey School of Engineering, will study the cells that lead the migration of deadly tumor cells through the body with a five-year $2.54 million National Institutes of Health (NIH) grant.
Network analysis useful in real-world applications for practitioners, study finds
A network survey among agencies that address cancer risk in rural Missouri and Illinois, conducted by the Brown School and the School of Medicine’s Implementation Science Center for Cancer Control, was found to be useful in helping those practitioners identify gaps, plan for how to establish future relationships and strengthen collaboration.
Investigational drug attacks synovial sarcoma, a rare type of tumor
A new study from Washington University School of Medicine describes a potential new therapy for synovial sarcoma, a rare tumor of soft tissues.
Inappropriate antibiotics for nonhospitalized kids cost US at least $74 million
Antibiotics inappropriately prescribed to children resulted in at least $74 million in excess health-care costs in the U.S. in 2017, according to a new study from Washington University School of Medicine and The Pew Charitable Trusts.
Abnormal development of brain’s visual system may contribute to autism
A new study, led by researchers at Washington University School of Medicine and the University of North Carolina School of Medicine, has identified abnormalities in the development of the brain’s visual system in infants that may predispose them to developing autism.
Long COVID poses risks to vaccinated people, too
Vaccinated people with mild breakthrough COVID-19 infections can experience debilitating, lingering symptoms that affect the heart, brain, lungs and other parts of the body, according to researchers at Washington University School of Medicine and the Veterans Affairs St. Louis Health Care System.
Genetic roots of three mitochondrial diseases ID’d via new approach
Researchers at Washington University School of Medicine and the University of Wisconsin–Madison identified the genetic causes of three mitochondrial diseases by figuring out what dozens of poorly understood mitochondrial proteins do.
Older Stories